These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19590427)

  • 1. Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile.
    Richter JE
    Am J Med Sci; 2009 Aug; 338(2):89-95. PubMed ID: 19590427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.
    Richter JE; Pandolfino JE; Vela MF; Kahrilas PJ; Lacy BE; Ganz R; Dengler W; Oelschlager BK; Peters J; DeVault KR; Fass R; Gyawali CP; Conklin J; DeMeester T;
    Dis Esophagus; 2013; 26(8):755-65. PubMed ID: 22882487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of bile reflux in Barrett's esophagus.
    Richter JE
    Dig Dis; 2000-2001; 18(4):208-16. PubMed ID: 11356992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
    Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis.
    Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [If no-acid, no-heartburn? New physiopathological mechanisms of the gastroesophageal reflux disease].
    Remes-Troche JM; Ramírez-Cervantes KL; Vela MF
    Rev Gastroenterol Mex; 2011; 76(3):237-46. PubMed ID: 22041313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of heartburn.
    Ang D; Sifrim D; Tack J
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jul; 5(7):383-92. PubMed ID: 18542113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice.
    Vaezi MF; Richter JE
    Hepatogastroenterology; 1999; 46(25):40-7. PubMed ID: 10228763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors.
    Monaco L; Brillantino A; Torelli F; Schettino M; Izzo G; Cosenza A; Di Martino N
    World J Gastroenterol; 2009 Jan; 15(3):334-8. PubMed ID: 19140233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.
    Miwa H; Kondo T; Oshima T
    Curr Opin Gastroenterol; 2016 Jul; 32(4):344-52. PubMed ID: 27206157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of reflux composition on mucosal injury and esophageal function.
    Oh DS; Hagen JA; Fein M; Bremner CG; Dunst CM; Demeester SR; Lipham J; Demeester TR
    J Gastrointest Surg; 2006 Jun; 10(6):787-96; discussion 796-7. PubMed ID: 16769534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How reflux causes symptoms: reflux perception in gastroesophageal reflux disease.
    Weijenborg PW; Bredenoord AJ
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):353-64. PubMed ID: 23998974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.